A multi-device and multi-operator dataset from mobile network coverage on Android devices.

The demand for mobile coverage with adequate signal quality has triggered criticism due to the maturity of the Internet's diffusion in today's society. However, with the deployment of 5G networks, even 5G NSA by 4G LTE, the complexity of the operating environment of mobile networks has increased. To evaluate the behavior of mobile networks in terms of signal quality and other important metrics for mobile telephony, we developed a dataset consisting of 33 radio parameters that can collect up to 736,974 records generated daily by smartphones and tablets.

The Use of the Self-Selected Rest Interval Method Is as Effective for Optimizing Postactivation Performance Enhancement in Elite Athletes as Employing the Best Fixed Rest Interval.

Fontanetti, G, Barreto, RV, Junior, RC, Marangoni, V, Denadai, BS, Greco, CC, and Lima, LCR. The use of the self-selected rest interval method is as effective for optimizing postactivation performance enhancement in elite athletes as employing the best fixed rest interval. J Strength Cond Res 39(1): 10-15, 2025-This study investigated whether the adoption of a self-selected recovery interval (SSI) is more effective than the use of a fixed recovery interval (FRI) to elicit postactivation performance enhancement (PAPE).

The Role of the Pancreatic Extracellular Matrix as a Tissue Engineering Support for the Bioartificial Pancreas.

Type 1 diabetes mellitus (T1DM) is a chronic condition primarily managed with insulin replacement, leading to significant treatment costs. Complications include vasculopathy, cardiovascular diseases, nephropathy, neuropathy, and reticulopathy. Pancreatic islet transplantation is an option but its success does not depend solely on adequate vascularization.

New Oncologic Drugs from 2008 to 2023-Differences in Approval and Access between the United States, Europe and Brazil.

Introduction: Advancements in oncology have revolutionized cancer treatment, with new drugs being approved at different rates worldwide. Our objective was to evaluate the approval of new oncological drugs for solid tumors by the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Brazilian Health Regulatory Agency (ANVISA) since 2008.

Methods: Data were collected from public and online databases by searching for the date of submission, the date of the procedure, the date of approval, clinical indication, and drug characteristics.

Allopurinol versus Trimetazidine for the Treatment of Angina: A Randomized Clinical Trial.

Background: Recently, it was demonstrated that allopurinol, a xanthine oxidase inhibitor, has cardiovascular and anti-ischaemic properties and may be a metabolic antianginal agent option.Objective: The objective of this study was to evaluate the antianginal effect of allopurinol as a third drug for patients with stable coronary artery disease (CAD).

Methods: This was a randomized clinical trial between 2018 and 2020 including patients with CAD who maintained angina despite initial optimization with beta-blockers and calcium channel blockers.